Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion

Arch Gen Psychiatry. 1999 Apr;56(4):349-52. doi: 10.1001/archpsyc.56.4.349.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Chronic Disease
  • Drug Approval
  • Drug Evaluation / standards
  • Evaluation Studies as Topic
  • Humans
  • Hypnotics and Sedatives / adverse effects*
  • Hypnotics and Sedatives / therapeutic use
  • National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division*
  • Prevalence
  • Product Surveillance, Postmarketing
  • Professional Staff Committees
  • Randomized Controlled Trials as Topic / standards
  • Research Design / standards
  • Sleep Initiation and Maintenance Disorders / drug therapy*
  • Sleep Initiation and Maintenance Disorders / epidemiology
  • Triazolam / adverse effects*
  • Triazolam / therapeutic use
  • United States / epidemiology
  • United States Food and Drug Administration

Substances

  • Hypnotics and Sedatives
  • Triazolam